3D Bio Therapeutics Overview
- Founded
- 2014

- Status
- Private
- Employees
- 25

- Latest Deal Type
- Series A
- Latest Deal Amount
- $8.46M

- Investors
- 3
3D Bio Therapeutics General Information
Description
Developer of 3D-bioprinting and materials technologies designed to treat disease and congenital medical conditions. The company's technologies focus on regenerative medicine that precision manufactures living tissues to help the replacement of each individual patient's parts with tissues designed and created specifically for them, enabling doctors to have capabilities that permit the creation of living tissue implants for therapeutic applications.
Contact Information
- 430 East 29th Street
- 14th Floor
- New York, NY 10282
- United States
3D Bio Therapeutics Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
1. Early Stage VC (Series A) | 10-Apr-2019 | $8.46M | 00.000 | 000.00 | Completed | Pre-Clinical Trials |
3D Bio Therapeutics Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series A | 0,000,000 | 00.000000 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
3D Bio Therapeutics Executive Team (8)
3D Bio Therapeutics Board Members (6)
Name | Representing | Role | Since |
---|---|---|---|
Harlan Weisman MD | Self | Executive Chairman | 000 0000 |
Kevin Slawin MD | Self | Board Member | 000 0000 |
Matthew Fitzpatrick | 3D Bio Therapeutics | Board Member | 000 0000 |
Michael Bator | Self | Board Member | 000 0000 |
Scott Dylla Ph.D | Self | Board Member | 000 0000 |
3D Bio Therapeutics Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial3D Bio Therapeutics Investors (3)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Blue Collective | PE/Buyout | Minority | 000 0000 | 000000 0 | |
Hibiscus Capital Management | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
Kairos Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |